Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription.

Muralidhar S, Doniger J, Mendelson E, Araujo JC, Kashanchi F, Azumi N, Brady JN, Rosenthal LJ.

J Virol. 1996 Dec;70(12):8691-700.

2.

Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Doniger J, Muralidhar S, Rosenthal LJ.

Clin Microbiol Rev. 1999 Jul;12(3):367-82. Review.

3.

A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation.

Thompson J, Doniger J, Rosenthal LJ.

Arch Virol. 1994;136(1-2):161-72.

PMID:
8002783
4.

Identification of two promoters within human cytomegalovirus morphologic transforming region II.

Inamdar A, Thompson J, Kashanchi F, Doniger J, Brady JN, Rosenthal LJ.

Intervirology. 1992;34(3):146-53.

PMID:
1338782
5.

Differences in retention and expression of transfected human cytomegalovirus Towne XbaI-E transforming fragment in human cervical and NIH 3T3 lines.

Choudhury S, Woodworth CD, Inamdar A, el-Beik T, DiPaolo JA, Rosenthal LJ.

Intervirology. 1992;33(4):187-96.

PMID:
1326497
6.

Functional analysis of human cytomegalovirus morphological transforming region II (mtrII).

Razzaque A, Zhu F, Jones C.

Virology. 1991 Mar;181(1):399-402.

PMID:
1847262
7.

The human cytomegalovirus mtrII colinear region in strain Tanaka is transformation defective.

Jahan N, Razzaque A, Brady J, Rosenthal LJ.

J Virol. 1989 Jun;63(6):2866-9.

8.

Human herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53.

Kashanchi F, Araujo J, Doniger J, Muralidhar S, Hoch R, Khleif S, Mendelson E, Thompson J, Azumi N, Brady JN, Luppi M, Torelli G, Rosenthal LJ.

Oncogene. 1997 Jan 23;14(3):359-67.

9.

Inhibition of p53 transcriptional activity by human cytomegalovirus UL44.

Kwon Y, Kim MN, Young Choi E, Heon Kim J, Hwang ES, Cha CY.

Microbiol Immunol. 2012 May;56(5):324-31. doi: 10.1111/j.1348-0421.2012.00446.x.

10.
11.

Localization and DNA sequence analysis of the transforming domain (mtrII) of human cytomegalovirus.

Razzaque A, Jahan N, McWeeney D, Jariwalla RJ, Jones C, Brady J, Rosenthal LJ.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5709-13.

12.

Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.

Deb S, Jackson CT, Subler MA, Martin DW.

J Virol. 1992 Oct;66(10):6164-70.

14.

Multiple transforming regions of human cytomegalovirus DNA.

el-Beik T, Razzaque A, Jariwalla R, Cihlar RL, Rosenthal LJ.

J Virol. 1986 Nov;60(2):645-52.

15.

Cellular homeoproteins, SATB1 and CDP, bind to the unique region between the human cytomegalovirus UL127 and major immediate-early genes.

Lee J, Klase Z, Gao X, Caldwell JS, Stinski MF, Kashanchi F, Chao SH.

Virology. 2007 Sep 15;366(1):117-25. Epub 2007 May 18.

17.

Interaction of human polyomavirus BK with the tumor-suppressor protein p53.

Shivakumar CV, Das GC.

Oncogene. 1996 Jul 18;13(2):323-32.

PMID:
8710371
19.

Mutational analysis of human papillomavirus type 16 E6 protein: transforming function for human cells and degradation of p53 in vitro.

Nakagawa S, Watanabe S, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T.

Virology. 1995 Oct 1;212(2):535-42.

20.

[Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus].

Lembo D, Angeretti A, Cavallo R, Gariglio M, Gribaudo G, Landolfo S.

G Batteriol Virol Immunol. 1994 Jan-Dec;86(1-12):43-54. Italian.

PMID:
8706975

Supplemental Content

Support Center